Biologics Maker Bacterin International At NYSE

Bacterin International, Inc. (NYSE Amex-Listed: BONE) visited the NYSE. In honor of the occasion, President and CEO, Guy Cook rang The Opening BellSM.

About Bacterin International, Inc. (NYSE Amex: BONE)

Bacterin International Holdings, Inc. develops, manufactures and markets biologics products to domestic and international markets. Bacterin's proprietary methods optimize the growth factors in human allografts to create the ideal stem cell scaffold to promote bone, subchondral repair and dermal growth. These products are used in a variety of applications including enhancing fusion in spine surgery, relief of back pain, promotion of bone growth in foot and ankle surgery, promotion of cranial healing following neurosurgery and subchondral repair in knee and other joint surgeries.

Bacterin's Medical Device division develops, employs, and licenses bioactive coatings for various medical device applications. Bacterin's strategic coating initiatives include antimicrobial coatings designed to inhibit biofilm formation and microbial contamination.  (Source: Bacterin International, Inc.)